Skip to main content
Family-based exome-wide assessment of maternal genetic effects on susceptibility to childhood B-cell acute lymphoblastic leukemia in hispanics.
Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project.
Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).
Postoperative radiation therapy for low-grade glioma: patterns of care between 1998 and 2006.
Response, survival, and toxicity after iodine-131-metaiodobenzylguanidine therapy for neuroblastoma in preadolescents, adolescents, and adults.
Clinical features and outcomes in patients with extraskeletal Ewing sarcoma.
Ethnic and racial differences in patients with Ewing sarcoma.
Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.